146 related articles for article (PubMed ID: 34991487)
1. Non-parametric estimation of reference adjusted, standardised probabilities of all-cause death and death due to cancer for population group comparisons.
Rutherford MJ; Andersson TM; Myklebust TÅ; Møller B; Lambert PC
BMC Med Res Methodol; 2022 Jan; 22(1):2. PubMed ID: 34991487
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013.
Dasgupta P; Cramb S; Kou K; Yu XQ; Baade PD
Cancer Epidemiol; 2019 Oct; 62():101568. PubMed ID: 31330423
[TBL] [Abstract][Full Text] [Related]
3. Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studies.
Lambert PC; Andersson TM; Rutherford MJ; Myklebust TÅ; Møller B
Int J Epidemiol; 2020 Oct; 49(5):1614-1623. PubMed ID: 32829393
[TBL] [Abstract][Full Text] [Related]
4. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
He VY; Condon JR; Baade PD; Zhang X; Zhao Y
Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
[TBL] [Abstract][Full Text] [Related]
5. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
6. [Mortality Atlas of the Campania Region. All-cause and cause-specific mortality at municipal level, 2006-2014].
Fusco M; Guida A; Bidoli E; Ciullo V; Vitale MF; Savoia F; Pirozzi A; Serraino D
Epidemiol Prev; 2020; 44(1 Suppl 1):1-144. PubMed ID: 33565290
[TBL] [Abstract][Full Text] [Related]
7. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
8. Estimating the crude probability of death due to cancer and other causes using relative survival models.
Lambert PC; Dickman PW; Nelson CP; Royston P
Stat Med; 2010 Mar; 29(7-8):885-95. PubMed ID: 20213719
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models.
Mozumder SI; Rutherford MJ; Lambert PC
BMC Med Res Methodol; 2021 Mar; 21(1):52. PubMed ID: 33706711
[TBL] [Abstract][Full Text] [Related]
11. Mortality by cause for eight regions of the world: Global Burden of Disease Study.
Murray CJ; Lopez AD
Lancet; 1997 May; 349(9061):1269-76. PubMed ID: 9142060
[TBL] [Abstract][Full Text] [Related]
12. Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models.
Eloranta S; Lambert PC; Andersson TM; Czene K; Hall P; Björkholm M; Dickman PW
BMC Med Res Methodol; 2012 Jun; 12():86. PubMed ID: 22726307
[TBL] [Abstract][Full Text] [Related]
13. [WebSurvCa: web-based estimation of death and survival probabilities in a cohort].
Clèries R; Ameijide A; Buxó M; Vilardell M; Martínez JM; Alarcón F; Cordero D; Díez-Villanueva A; Yasui Y; Marcos-Gragera R; Vilardell ML; Carulla M; Galceran J; Izquierdo Á; Moreno V; Borràs JM
Gac Sanit; 2018; 32(5):492-495. PubMed ID: 29357998
[TBL] [Abstract][Full Text] [Related]
14. Competing mortality risks among women aged 50-79 years when diagnosed with invasive breast cancer, Queensland, 1997-2012.
Dasgupta P; Aitken JF; Pyke C; Baade PD
Breast; 2018 Oct; 41():113-119. PubMed ID: 30029053
[TBL] [Abstract][Full Text] [Related]
15. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data.
Wright CM; Nowak AK; Halkett G; Moorin RE
BMC Public Health; 2020 Jun; 20(1):1002. PubMed ID: 32586298
[TBL] [Abstract][Full Text] [Related]
16. Estimating net survival: the importance of allowing for informative censoring.
Danieli C; Remontet L; Bossard N; Roche L; Belot A
Stat Med; 2012 Apr; 31(8):775-86. PubMed ID: 22281942
[TBL] [Abstract][Full Text] [Related]
17. Conditional crude probabilities of death for English cancer patients.
Wong KF; Lambert PC; Mozumder SI; Broggio J; Rutherford MJ
Br J Cancer; 2019 Nov; 121(10):883-889. PubMed ID: 31601960
[TBL] [Abstract][Full Text] [Related]
18. Challenges in the estimation of Net SURvival: The CENSUR working survival group.
Giorgi R;
Rev Epidemiol Sante Publique; 2016 Oct; 64(5):367-371. PubMed ID: 27793412
[TBL] [Abstract][Full Text] [Related]
19. How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.
Eloranta S; Adolfsson J; Lambert PC; Stattin P; Akre O; Andersson TM; Dickman PW
Cancer Causes Control; 2013 Mar; 24(3):505-15. PubMed ID: 23296456
[TBL] [Abstract][Full Text] [Related]
20. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
Cronin KA; Feuer EJ
Stat Med; 2000 Jul; 19(13):1729-40. PubMed ID: 10861774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
